Could qelbree tame ADHD and mood swings in adults?
NCT ID NCT06185985
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the drug Qelbree (viloxazine) in 161 adults with ADHD who also had mood symptoms. Participants took the medication for several weeks, and researchers tracked changes in ADHD symptoms using a standard rating scale. The goal was to see if Qelbree is both safe and effective for this specific group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Qelbree (viloxazine extended-release capsules)
What this could lead to
If successful, this could show that Qelbree is a safe and effective option for adults with ADHD who also have mood symptoms, potentially expanding treatment choices.
What could go wrong
This was an open-label trial with no placebo group, so results may be less reliable. The study is completed but not yet published, so we don't know the outcomes. Side effects are possible, as with any medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT / HYPERACTIVITY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ObvioHealth
New York, New York, 10001, United States